NCT04794478 - Evaluation of the Safety and Effectiveness of the Dexcom Continuous Glucose Monitoring (CGM) System | Biotech Hunter

Enrollment

482

Participants

Timeline

Start Date

February 19, 2021

Primary Completion Date

August 9, 2021

Study Completion Date

October 31, 2021

Conditions

Diabetes Mellitus

Interventions

DEVICE

Dexcom Continuous Glucose Monitoring System

Trial Locations (12)

UVA Center for Diabetes Technology, Charlottesville

Clinical Trials of Texas, Inc. (CTT), San Antonio

Diabetes & Glandular Disease Clinic, P.A., San Antonio

Endeavor Clinical Trials, San Antonio

Barbara Davis Center, Aurora

Rocky Mountain Clinical Research, Idaho Falls

Advanced Research, Ogden

ProSciento, Chula Vista

AMCR Institute, Escondido

Sansum Diabetes Research Institute, Santa Barbara

Diablo Clinical Research, Walnut Creek

Joslin Diabetes Center, Boston

All Listed Sponsors

lead

DexCom, Inc.

INDUSTRY